<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35728442</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1980-5322</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Clinics (Sao Paulo, Brazil)</Title><ISOAbbreviation>Clinics (Sao Paulo)</ISOAbbreviation></Journal><ArticleTitle>Frequency and factors associated with hospital readmission after COVID-19 hospitalization: the importance of post-COVID diarrhea.</ArticleTitle><Pagination><StartPage>100061</StartPage><MedlinePgn>100061</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100061</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clinsp.2022.100061</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1807-5932(22)02291-8</ELocationID><Abstract><AbstractText Label="PURPOSE">The aim of this study was to describe the incidence and risk factors for hospital readmission and infection during the months after COVID-19 hospital admission.</AbstractText><AbstractText Label="METHODS">This prospective study included adult patients who were hospitalized due to COVID-19 and had been discharged from April&#xa0;2020 to August&#xa0;2020. All patients had a medical evaluation with a structured questionnaire&#xa0;6&#xa0;to&#xa0;11&#xa0;months after hospital admission. The authors included only patients with confirmed COVID-19 by RT-PCR. Patients with pregnant/postpartum women, with a proven COVID-19 reinfection or incapable of answering the questionnaire were excluded.</AbstractText><AbstractText Label="RESULTS">A total of&#xa0;822&#xa0;patients completed the follow-up assessment, and 68%&#xa0;reported at least one recurrent symptom related to COVID-19. The most frequent symptom was myalgia (42%). Thirty-two percent of patients visited an emergency room after COVID-19 hospitalization, and 80&#xa0;(10%) patients required re-hospitalization. Risk factors for hospital readmission were orotracheal intubation during COVID-19 hospitalization (p&#xa0;=&#xa0;0.003, OR&#xa0;=&#xa0;2.14), Charlson score (p&#xa0;=&#xa0;0.002, OR&#xa0;=&#xa0;1.21), congestive heart failure (p&#xa0;=&#xa0;0.005, OR&#xa0;=&#xa0;2.34), peripheral artery disease (p&#xa0;=&#xa0;0.06, OR&#xa0;=&#xa0;2.06) and persistent diarrhea after COVID-19 hospitalization discharge (p&#xa0;=&#xa0;0.02, OR&#xa0;=&#xa0;1.91). The main cause of hospital readmission was an infection, 43&#xa0;(54%). Pneumonia was the most frequent infection (29%).</AbstractText><AbstractText Label="CONCLUSIONS">The presence of symptoms after six months of COVID-19 diagnosis was frequent, and hospital readmission was relatively high.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 HCFMUSP. Published by Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Freire</LastName><ForeName>Maristela Pinheiro</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Working Committee for Hospital Epidemiology and Infection Control, Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, SP, Brazil. Electronic address: maristelapf@uol.com.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Maura Salaroli</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Working Committee for Hospital Epidemiology and Infection Control, Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magri</LastName><ForeName>Marcello Mihailenko Chaves</ForeName><Initials>MMC</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavares</LastName><ForeName>Bruno Melo</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Working Committee for Hospital Epidemiology and Infection Control, Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nastri</LastName><ForeName>Ana Catharina De Seixas Santos</ForeName><Initials>ACSS</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filho</LastName><ForeName>Geraldo Busatto</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Laboratory of Psychiatric Neuroimaging (LIM-21), Department and Institute of Psychiatry, Faculdade de Medicina, Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>HCFMUSP COVID-19 Study Group</CollectiveName></Author><Author ValidYN="Y"><LastName>Levin</LastName><ForeName>Anna S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clinics (Sao Paulo)</MedlineTA><NlmUniqueID>101244734</NlmUniqueID><ISSNLinking>1807-5932</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003967" MajorTopicYN="N">Diarrhea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diarrhea</Keyword><Keyword MajorTopicYN="N">Dysbiosis</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Myalgia</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>21</Day><Hour>18</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35728442</ArticleId><ArticleId IdType="pmc">PMC9189119</ArticleId><ArticleId IdType="doi">10.1016/j.clinsp.2022.100061</ArticleId><ArticleId IdType="pii">S1807-5932(22)02291-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johns Hopkins University. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) n.d. https://coronavirus.jhu.edu/map.html (accessed September 21, 2021).</Citation></Reference><Reference><Citation>Gupta A, Madhavan MV., Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Morales AJ, Cardona-Ospina JA, Guti&#xe9;rrez-Ocampo E, Villamizar-Pe&#xf1;a R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;34</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102608</ArticleId><ArticleId IdType="pubmed">32179124</ArticleId></ArticleIdList></Reference><Reference><Citation>Demeco A, Marotta N, Barletta M, Pino I, Marinaro C, Petraroli A, et al. Rehabilitation of patients post-COVID-19 infection: a literature review. J Int Med Res. 2020;48(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7450453</ArticleId><ArticleId IdType="pubmed">32840156</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowicz K, G&#x105;sowski J, Michel J-P, Veronese N. Post-COVID-19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res. 2021;33(10):2887&#x2013;2898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8323089</ArticleId><ArticleId IdType="pubmed">34328636</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeratne T, Crewther S. Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community. J Neurol Sci. 2020;419</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550857</ArticleId><ArticleId IdType="pubmed">33070003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021;75(3):e13746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Busatto GF, De Ara&#xfa;jo AL, Duarte AJDS, Levin AS, Guedes BF, Kallas EG, et al. Post-acute sequelae of SARS-CoV-2 infection (PASC): A protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil. BMJ Open. 2021;11(6)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249176</ArticleId><ArticleId IdType="pubmed">34193506</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Diarrhoeal disease n.d. https://www.who.int/news-room/fact-sheets/detail/diarrhoeal-disease.</Citation></Reference><Reference><Citation>Craig CL, Marshall AL, SJ, STR, M M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sport Exerc. 2003;35(8):1381&#x2013;1395. ????</Citation><ArticleIdList><ArticleId IdType="pubmed">12900694</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazilian Market Research Association. Crit&#xe9;rio de classifica&#xe7;&#xe3;o econ&#xf4;mica Brasil 2019. https://www.abep.org/criterio-brasil (accessed September 17, 2021).</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly JP, Wang XQ, Iwashyna TJ, Prescott HC. Readmission and death after initial hospital discharge among patients with COVID-19 in a large multihospital system. JAMA. 2021;325(3):304&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737131</ArticleId><ArticleId IdType="pubmed">33315057</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhr RG, Jackson NJ, Kominski GF, Dubinett SM, Ong MK, Mangione CM. Comorbidity and thirty-day hospital readmission odds in chronic obstructive pulmonary disease: A comparison of the Charlson and Elixhauser comorbidity indices. BMC Health Serv Res. 2019;19:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6794890</ArticleId><ArticleId IdType="pubmed">31615508</ArticleId></ArticleIdList></Reference><Reference><Citation>Nematshahi M, Soroosh D, Neamatshahi M, Attarian F, Rahimi F. Factors predicting readmission in patients with COVID-19. BMC Res Notes. 2021;14(1):374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474946</ArticleId><ArticleId IdType="pubmed">34565442</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang DH, Roy DJ, Gu BJ, Hassett LC, McCoy RG. Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. JACC Basic to Transl Sci. 2021;6(9):796&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8442719</ArticleId><ArticleId IdType="pubmed">34541421</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nster C, Busse R, Spoden M, Rombey T, Schillinger G, Hoffmann W, et al. 6-month mortality and readmissions of hospitalized COVID-19 patients: A nationwide cohort study of 8,679 patients in Germany. PLoS One. 2021;16(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8341502</ArticleId><ArticleId IdType="pubmed">34351975</ArticleId></ArticleIdList></Reference><Reference><Citation>Donati Zeppa S, Agostini D, Piccoli G, Stocchi V, Sestili P. Gut microbiota status in COVID-19: an unrecognized player? Front Cell Infect Microbiol. 2021;16(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7725702</ArticleId><ArticleId IdType="pubmed">33324572</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhan H, Zhang F, Liu Q, Tso EYK, Lui GCY, et al. Alterations in fecal fungal microbiome of patients with covid-19 during time of hospitalization until discharge. Gastroenterology. 2020;159(4):1302&#x2013;1310. .e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GCY, Zhang F, Liu Q, Li AYL, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17:219&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">28260787</ArticleId></ArticleIdList></Reference><Reference><Citation>Villapol S. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl Res. 2020;226:57&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438210</ArticleId><ArticleId IdType="pubmed">32827705</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry ZS, Williams JD, Vahia A, Fadel R, Parraga Acosta T, Prashar R, et al. Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A cohort study. Am J Transplant. 2020;20(11):3051&#x2013;3060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405160</ArticleId><ArticleId IdType="pubmed">32654332</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>